US EditionPublished • loading... • Updated
Jordi Sánchez (Bayer): 'if We Don't Get More Investment in R & D and Production, Europe Will Continue Behind the United States and China'
Summary by elcorreoweb.es
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
He spent about five years in international positions before returning to what, for him, is "home." Jordi Sánchez, until then director of Bayer's pharmaceutical business in Spain, passed a year and a half ago to occupy the position of CEO. The manager presented this week the first results of an exercise governed by him from beginning to end. The balance sheet has remained somewhat poor because of the withdrawal of a fungicide from the market, but…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
